Found: 5
Select item for more details and to access through your institution.
New Approaches to Prediction of Immune Responses to Therapeutic Proteins during Preclinical Development.
- Published in:
- Drugs in R&D, 2008, v. 9, n. 6, p. 385, doi. 10.2165/0126839-200809060-00004
- By:
- Publication type:
- Article
Characterisation of a Novel Anti-CD52 Antibody with Improved Efficacy and Reduced Immunogenicity.
- Published in:
- PLoS ONE, 2015, v. 10, n. 9, p. 1, doi. 10.1371/journal.pone.0138123
- By:
- Publication type:
- Article
Use of In Vitro Assays to Assess Immunogenicity Risk of Antibody-Based Biotherapeutics.
- Published in:
- PLoS ONE, 2016, v. 11, n. 8, p. 1, doi. 10.1371/journal.pone.0159328
- By:
- Publication type:
- Article
A deimmunised form of the ribotoxin, a-sarcin, lacking CD4<sup>+</sup> T cell epitopes and its use as an immunotoxin warhead.
- Published in:
- PEDS: Protein Engineering, Design & Selection, 2016, v. 29, n. 11, p. 531, doi. 10.1093/protein/gzw045
- By:
- Publication type:
- Article
Prediction of Immunogenicity of Therapeutic Proteins: Validity of Computational Tools.
- Published in:
- BioDrugs, 2010, v. 24, n. 1, p. 1, doi. 10.2165/11318560-000000000-00000
- By:
- Publication type:
- Article